Victory Capital Management
IMNM icon

Victory Capital Management’s Immunome IMNM Stock Holding History

Victory Capital Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Buy
47,524
+164
+0.3% +$3.51K ﹤0.01% 1901
2026
Q1 		$1.04M Buy
47,360
+37,087
+361% +$825K ﹤0.01% 1831
2025
Q4 		$221K Buy
+10,273
New +$180K ﹤0.01% 2180
2024
Q4 		– Sell
-730,785
Closed -$10.7M – 2504
2024
Q3 		$10.7M Buy
730,785
+237,497
+48% +$3.37M 0.01% 1087
2024
Q2 		$5.97M Buy
493,288
+138,526
+39% +$2.17M 0.01% 1216
2024
Q1 		$8.76M Buy
+354,762
New +$7.2M 0.01% 1100

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Victory Capital Management's IMNM Position: Q2 2026 in Review

Victory Capital Management increased its Immunome (IMNM) stake by 0.35% in Q2 2026, buying an estimated $3.51K and bringing the position to 47,524 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

Victory Capital Management first reported a position in IMNM in Q1 2024 and has held it in 6 quarters since. The position peaked at $10.7M in Q3 2024. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Victory Capital Management held 47,524 shares of Immunome worth $1.01M as of Q2 2026.
  • Victory Capital Management bought 164 Immunome shares in Q2 2026, an estimated $3.51K.
  • Immunome made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #1901 holding.
  • Victory Capital Management first reported a position in Immunome in Q1 2024 and has held it in 6 quarters since.
  • Victory Capital Management's Immunome position peaked at $10.7M in Q3 2024.
  • 203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.